Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Articles published by CDR-Life AG CDR-Life Announces Fourth Milestone Achievement with Boehringer Ingelheim in Phase 1 Geographic Atrophy Trial April 30, 2024 From CDR-Life AG Via GlobeNewswire CDR-Life to Present Tumor Targeting Capabilities of M-gager® Platform at the TCR-Based Therapies for Solid Tumors Summit April 23, 2024 From CDR-Life AG Via GlobeNewswire CDR-Life Unveils Results on T-Cell Engagers Targeting Hard-to-Treat Solid Tumors at AACR 2024 April 05, 2024 From CDR-Life AG Via GlobeNewswire CDR-Life Announces FDA Clearance of IND Application for CDR404 for Treatment of Solid Tumors January 23, 2024 From CDR-Life AG Via GlobeNewswire CDR-Life Announces First Patient Dosed in Phase 1 Study with Boehringer Ingelheim Evaluating Potential Treatment for Geographic Atrophy December 06, 2023 From CDR-Life AG Via GlobeNewswire CDR-Life Presents Findings from Two Studies in Preparation of Phase 1 Trial with Immunotherapy CDR404 for Treatment of Solid Tumors at SITC 2023 November 03, 2023 From CDR-Life AG Via GlobeNewswire CDR-Life Presents Precise Tumor and Patient Selection for CDR404: First-of-its-Kind Dual MAGE-A4 T-cell Engager, at ESMO Congress 2023 October 23, 2023 From CDR-Life AG Via GlobeNewswire CDR-Life Announces Second Milestone Achievement with Boehringer Ingelheim in Developing Antibody Fragment-based Therapeutics for Geographic Atrophy August 02, 2023 From CDR-Life AG Via GlobeNewswire Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.